Literature DB >> 11158092

Use of an enzyme immunoassay does not eliminate the need to analyze multiple stool specimens for sensitive detection of Giardia lamblia.

K L Hanson1, C P Cartwright.   

Abstract

The relative sensitivities of a commercially available enzyme immunoassay (EIA) (ProSpecT Giardia; Alexon-Trend Inc., Ramsey, Minn.) and conventional ovum-and-parasite (O&P) examination for the detection of Giardia lamblia in preserved stool specimens were determined. Paired stool samples collected independently within a 7-day period from 103 patients were analyzed by both methods. A total of 54 specimens from 30 patients (18 asymptomatically infected with G. lamblia and 12 with symptoms consistent with intestinal giardiasis) were determined to be positive for G. lamblia, of which 48 (88.9%) were positive by microscopy and 52 (96.3%) were positive by EIA. Both specimens submitted were positive for G. lamblia by O&P examination for 66.7% (20 of 30) of the positive patients; for 26.7% (8 of 30) a single specimen was positive by O&P examination, and for 6.7% (2 of 30) of those determined to be infected with G. lamblia, both samples were negative by microscopy. The sensitivity of conventional O&P examination was somewhat higher in symptomatically infected individuals, with 75% (9 of 12) of patients in this category having G. lamblia detected in both samples, compared with 61% (11 of 18) of asymptomatic patients. A total of 24 positive patients (80%) had G. lamblia antigen detected by EIA in both submitted samples, 4 positive patients (13.3%) had one specimen positive by EIA, and the EIA was negative in both specimens from 2 infected individuals (6.5%), the sensitivity of EIA was substantially equivalent in asymptomatic and symptomatic individuals (77 versus 83% of patients with positive results on both specimens). Although the sensitivity of EIA for the detection of G. lamblia on a single stool specimen was somewhat higher than that of conventional O&P examination in symptomatic patients (83 versus 75%), in asymptomatic patients (77 versus 61%), and overall (80 versus 67%), examination of two specimens by either EIA or microscopy was necessary to achieve a diagnostic sensitivity of greater than 90%.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11158092      PMCID: PMC87761          DOI: 10.1128/JCM.39.2.474-477.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Utility of multiple-stool-specimen ova and parasite examinations in a high-prevalence setting.

Authors:  C P Cartwright
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

2.  Numbers of Giardia in the feces of infected children.

Authors:  M Danciger; M Lopez
Journal:  Am J Trop Med Hyg       Date:  1975-03       Impact factor: 2.345

3.  A rapid staining procedure for intestinal amoebae and flagellates.

Authors:  W B WHEATLEY
Journal:  Am J Clin Pathol       Date:  1951-10       Impact factor: 2.493

4.  Comparison of nine commercially available enzyme-linked immunosorbent assays for detection of Giardia lamblia in fecal specimens.

Authors:  W E Aldeen; K Carroll; A Robison; M Morrison; D Hale
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

5.  Stool diagnosis of giardiasis using a commercially available enzyme immunoassay to detect Giardia-specific antigen 65 (GSA 65).

Authors:  J D Rosoff; C A Sanders; S S Sonnad; P R De Lay; W K Hadley; F F Vincenzi; D M Yajko; P D O'Hanley
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

6.  Evaluation of nine immunoassay kits (enzyme immunoassay and direct fluorescence) for detection of Giardia lamblia and Cryptosporidium parvum in human fecal specimens.

Authors:  L S Garcia; R Y Shimizu
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

7.  Application of rejection criteria for stool ovum and parasite examinations.

Authors:  A J Morris; M L Wilson; L B Reller
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

8.  Evaluation of rapid commercial enzyme immunoassay for detection of Giardia lamblia in formalin-preserved stool specimens.

Authors:  E H Scheffler; L L Van Etta
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

9.  Evaluation of a commercially available ELISA assay for detection of Giardia lamblia in fecal specimens.

Authors:  W E Aldeen; D Hale; A J Robison; K Carroll
Journal:  Diagn Microbiol Infect Dis       Date:  1995-02       Impact factor: 2.803

10.  Sensitivity of microscopy versus enzyme immunoassay in the laboratory diagnosis of giardiasis.

Authors:  T G Mank; J O Zaat; A M Deelder; J T van Eijk; A M Polderman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-08       Impact factor: 5.103

View more
  17 in total

1.  ImmunoCard STAT! cartridge antigen detection assay compared to microplate enzyme immunoassay and modified Kinyoun's acid-fast staining technique for detection of Cryptosporidium in fecal specimens.

Authors:  Amal Abdul-Rasheed El-Moamly; Mohamed Aly El-Sweify
Journal:  Parasitol Res       Date:  2011-08-14       Impact factor: 2.289

2.  A Comparison of Microscopy and Enzyme Linked Immunosorbent Assay for Diagnosis of Giardia lamblia in Human Faecal Specimens.

Authors:  Noor Jahan; Razia Khatoon; Siraj Ahmad
Journal:  J Clin Diagn Res       Date:  2014-11-20

3.  Detection of Giardia lamblia antigens in human fecal specimens by a solid-phase qualitative immunochromatographic assay.

Authors:  Lynne S Garcia; John Paul Garcia
Journal:  J Clin Microbiol       Date:  2006-10-25       Impact factor: 5.948

4.  Comparison of microscopy, rapid immunoassay, and molecular techniques for the detection of Giardia lamblia and Cryptosporidium parvum.

Authors:  Salah H Elsafi; Thekra N Al-Maqati; Mohi I Hussein; Ahmed A Adam; Mohamed M Abu Hassan; Eidan M Al Zahrani
Journal:  Parasitol Res       Date:  2013-02-15       Impact factor: 2.289

5.  Giardiasis in patients with dyspeptic symptoms.

Authors:  Javed Yakoob; Wasim Jafri; Shahab Abid; Nadim Jafri; Saeed Hamid; Hasnain Ali Shah; Lubna Rizvi; Muhammad Islam; Hizbullah Shaikh
Journal:  World J Gastroenterol       Date:  2005-11-14       Impact factor: 5.742

6.  Use of Serologic Responses against Enteropathogens to Assess the Impact of a Point-of-Use Water Filter: A Randomized Controlled Trial in Western Province, Rwanda.

Authors:  Laura Divens Zambrano; Jeffrey W Priest; Emil Ivan; John Rusine; Corey Nagel; Miles Kirby; Ghislaine Rosa; Thomas F Clasen
Journal:  Am J Trop Med Hyg       Date:  2017-07-27       Impact factor: 2.345

7.  Evaluation of three commercial assays for detection of Giardia and Cryptosporidium organisms in fecal specimens.

Authors:  Stephanie P Johnston; Melissa M Ballard; Michael J Beach; Louise Causer; Patricia P Wilkins
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

8.  Treatment of giardiasis in common marmosets (Callithrix jacchus) with tinidazole.

Authors:  Joshua A Kramer; Audra M Hachey; Lynn M Wachtman; Keith G Mansfield
Journal:  Comp Med       Date:  2009-04       Impact factor: 0.982

9.  Evaluation of a novel kit (TF-Test) for the diagnosis of intestinal parasitic infections.

Authors:  Jancarlo Ferreira Gomes; Sumie Hoshino-Shimizu; Luiz Cândido S Dias; Ana Júlia S A Araujo; Vera L P Castilho; Fátima A M A Neves
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

10.  Prevalence of giardiasis in children attending semi-urban daycare centres in Guatemala and comparison of 3 giardia detection tests.

Authors:  Terri-Lynn Duffy; Gabriela Montenegro-Bethancourt; Noel W Solomons; Miodrag Belosevic; M Thomas Clandinin
Journal:  J Health Popul Nutr       Date:  2013-06       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.